Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111468) titled 'Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Yuhan Corporation
Condition:
Acute Bronchitis
Intervention:
Drug: YHP2401
Drug: YHR2402
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: October 17, 2025
Target Sample Size: 279
Countries of Recruitment:
Korea, Republic of
To know more, visit https://clinicaltri...